Comparative Clinical Analysis of Oblique Lateral Interbody Fusion at L5/S1 versus Minimally Invasive Transforaminal Interbody Fusion (MIS-TLIF) for Degenerative Lumbosacral Disorders

Introduction: Since 2015, we have performed minimally invasive oblique lateral interbody fusion (OLIF) at L5/S1 for various lumbosacral spine disorders using percutaneous pedicle screws. This study evaluated the clinical and radiologic results between OLIF at L5/S1 and minimally invasive transforaminal interbody fusion (MIS-TLIF) for single to multilevel degenerative lumbosacral disorders. Methods: A total of 124 patients underwent either OLIF (62 cases) or MIS-TLIF (62 cases). The applied disorders were L5 isthmic spondylolisthesis, foraminal stenosis, pseudarthrosis, adjacent segment degeneration, a combination of L4/5 and L5/S1 pathology, and others. We performed OLIF with posterior percutaneous fixation in the same lateral position. MIS-TLIF was performed with modified cortical bone trajectory screws. The operation time (OT), estimated blood loss (EBL), JOABPEQ effectiveness rate (%),Visual Analog Scale (VAS), fusion rate, radiologic segmental alignment, and complications were evaluated. Conclusions: The OLIF group demonstrated less pain as well as better low-back and gait functions at follow-up. The minimally invasive anterolateral fusion employing OLIF at L5/S1 using percutaneous screws serves as a viable and effective procedure with less residual LBP and high fusion rate.